Healthcare
Alcimed Position paper – DIGITAL HEALTH IN TIMES OF PANDEMICS
Alcimed Position Paper - DIGITAL HEALTH IN TIMES OF PANDEMICS: How will the Covid-19 crisis help build a new place for digital health?
Healthcare
Alcimed Position Paper - DIGITAL HEALTH IN TIMES OF PANDEMICS: How will the Covid-19 crisis help build a new place for digital health?
Articles
Driven by rapid technological advances, genetic testing is now within the direct reach of consumers. This fast-growing market is pushing many companies to expand, particularly in Asian markets. And ...
Articles
Air pollution is a subject at the heart of current concerns. For several weeks, researchers and doctors have warned about the correlation between air pollution and sensitivity to respiratory ...
Cross-sector
Improving knowledge and monitoring of rare diseases is a major public health issue. These diseases are often chronic, serious and affect all medical specialties. Knowledge of rare diseases is ...
Healthcare
CAR T-cell therapies gain more and more attention as being innovative immunotherapy options for cancer patients. Although being researched for years, the approval reach of new treatments is yet ...
Articles
High costs of new innovative drugs obviously raise the issue of the capacity of national health insurance systems to finance them, especially as they are often effective in some cases only. The ...
Healthcare
The forecasted Digital therapeutics (DTx) global market annual growth for the upcoming years gravitates around 20%. This fast development triggers questions concerning the place of DTx in the ...
Cross-sector
Over the last few years, air pollution (microparticles, lead, NO2, SO2 and CO) has received more and more attention due to human health risks. Air pollution is currently measured using stationary ...
Articles
Over the past few months, the COVID-19 outbreak has forced countries around the world to implement lockdown measures. While many of these countries are now entering a phase of deconfinement, it is ...
Cross-sector
In the current COVID-19 context, the regulations concerning the practice of telemedicine are becoming more flexible in France and no longer constitute a barrier to its development. However, access to ...